Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antibody Drug Conjugates Market
Antibody Drug Conjugates Market Share
- Report ID: GMI5940
- Published Date: Jun 2023
- Report Format: PDF
Antibody Drug Conjugates Market Share
Major market players operating in the antibody drug conjugates market include :
- Seagen Inc.
- Pfizer Inc.
- F.Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Frequently Asked Questions (FAQ) :
Global market size for antibody drug conjugates was USD 7.7 billion in 2023 and will witness a 14.8% CAGR from 2024 to 2032.
The cleavable linker segment will surpass USD 14.3 billion by 2032 as to significant advancements in antibody-drug conjugates that enable to release of the cytotoxic payload specifically within cancer cells, thereby enhancing treatment efficacy.
North America market share for antibody drug conjugates was over 49.5% in 2022 owing to the increasing prevalence of cancer and the growing demand for targeted therapies in the region.
Seagen Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc among others.
Antibody Drug Conjugates Market Scope
×
Get a free sample of
Antibody Drug Conjugates Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below